Skip to main content

T32 Program Graduate Receives ENVISION Stroke Research Fellowship

June 11, 2026
We are pleased to announce that Mary Jackson, OTR/L, OTD, MS, a 2026 graduate of the T32 Program on Integrative Medicine (PIM), has been selected to receive the Eastern North Carolina and Southern Virginia RegIonal Stroke trIal cONsortium (ENVISION) Fellowship. The ENVISION Fellowship is a joint collaboration between Duke University and...

POST‑ICECAP Study Examines Long‑Term Recovery After Cardiac Arrest

June 10, 2026
Survival after out‑of‑hospital cardiac arrest is a major milestone—but for patients and families, it marks the beginning of a long and uncertain recovery journey. Questions about cognition, physical function, emotional health, and quality of life often persist for months or longer, yet clinicians have limited long‑term data to guide expectations...

New UNC Study Explores Non‑Opioid Relief for Severe Headache After Subarachnoid Hemorrhage

June 10, 2026
Severe headache is one of the most distressing symptoms experienced by patients with aneurysmal subarachnoid hemorrhage (SAH). In the neurocritical care setting, pain control often relies on opioid medications—drugs that can cause sedation and complicate frequent neurologic examinations during a critical period of recovery. A new clinical trial underway at...

Alicia Crutchfield Named UNC Nurse of the Year

June 10, 2026
UNC Neurology proudly celebrates Alicia Crutchfield, MSN, RN, CCRN, Clinical Nurse IV in the Neuroscience Intensive Care Unit (NSICU), who has been named a UNC Medical Center Nurse of the Year. This prestigious award recognizes individuals who demonstrate excellence in UNC’s core values while making exceptional professional contributions. Alicia exemplifies...

Neurology Named Clinical Site in n‑Lorem Nano‑Rare Disease Network

June 9, 2026
UNC Neurology is proud to be a clinical site within the national n‑Lorem Foundation nano‑rare patient research and treatment network, an innovative initiative advancing personalized therapies for patients with ultra‑rare genetic neurological disorders. The n‑Lorem Foundation, a nonprofit established in 2020, is dedicated to discovering, developing, and providing individualized antisense...

Neurology Showcases Innovation and Collaboration at Neurology Day 2026

June 3, 2026
The UNC Department of Neurology brought together researchers, clinicians, trainees, and community members for Neurology Day 2026, a signature annual event celebrating the scope and impact of neurological research across the department. Held on May 14, 2026, the event highlighted clinical and basic science research as well as showcased neurology...

Dr. Deanna Saylor, MD, MHS, Receives Prestigious ANA Derek Denny-Brown Award

June 1, 2026
Deanna Saylor, MD, MHS, has been selected as the 2026 recipient of the American Neurological Association’s (ANA) Derek Denny-Brown Young Neurological Scholar Award – Physician-Scientist Clinical, a national honor recognizing outstanding clinical research by early-career neurologists. The Derek Denny-Brown Award is presented annually to physician-scientists whose work demonstrates exceptional promise...

CAMRI Contributes Perspective on Autism Neuroimaging in Nature Neuroscience

May 20, 2026
Researchers in the Department of Neurology at the University of North Carolina at Chapel Hill, including Drs. Tatiana Shnitko, Alex Lin, and Ian Shih, recently shared their views in Nature Neuroscience through an article titled “Parsing autism spectrum heterogeneity through fMRI.” Autism is known for its wide range of clinical...

Dr. Monica Diaz Promoted to Associate Professor

May 19, 2026
The Department of Neurology at the University of North Carolina at Chapel Hill is pleased to announce the promotion of Dr. Monica M. Diaz, MD, MS, to Associate Professor of Neurology. Dr. Diaz has been a valued member of the UNC faculty since 2020, serving as a tenure-track Assistant Professor....

Dr. James F. Howard Jr. Leads Global Study Advancing Treatment for Myasthenia Gravis

May 12, 2026
A major advancement in the treatment of generalized myasthenia gravis (gMG) is expanding options for patients worldwide, supported by the leadership of UNC Neurology’s Dr. James F. Howard Jr. The U.S. Food and Drug Administration recently approved an expanded indication for efgartigimod (VYVGART®), making it available to all adult patients...